DK3835298T3 - Nye chromanderivater med østrogenreceptornedbrydende aktivitet og anvendelser heraf - Google Patents

Nye chromanderivater med østrogenreceptornedbrydende aktivitet og anvendelser heraf Download PDF

Info

Publication number
DK3835298T3
DK3835298T3 DK20169240.7T DK20169240T DK3835298T3 DK 3835298 T3 DK3835298 T3 DK 3835298T3 DK 20169240 T DK20169240 T DK 20169240T DK 3835298 T3 DK3835298 T3 DK 3835298T3
Authority
DK
Denmark
Prior art keywords
chromande
derivatives
new
estrogen receptor
degrading activity
Prior art date
Application number
DK20169240.7T
Other languages
Danish (da)
English (en)
Inventor
Jie Fan
Yimin Qian
Wei He
Ke Liu
Original Assignee
Accutar Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accutar Biotechnology Inc filed Critical Accutar Biotechnology Inc
Application granted granted Critical
Publication of DK3835298T3 publication Critical patent/DK3835298T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK20169240.7T 2019-12-12 2020-04-13 Nye chromanderivater med østrogenreceptornedbrydende aktivitet og anvendelser heraf DK3835298T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962947213P 2019-12-12 2019-12-12

Publications (1)

Publication Number Publication Date
DK3835298T3 true DK3835298T3 (da) 2024-07-29

Family

ID=70289288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20169240.7T DK3835298T3 (da) 2019-12-12 2020-04-13 Nye chromanderivater med østrogenreceptornedbrydende aktivitet og anvendelser heraf

Country Status (11)

Country Link
US (2) US10800770B1 (https=)
EP (2) EP3835298B1 (https=)
JP (2) JP7662639B2 (https=)
KR (1) KR102942706B1 (https=)
CN (2) CN115003295B (https=)
CA (1) CA3164202A1 (https=)
DK (1) DK3835298T3 (https=)
ES (1) ES2986594T3 (https=)
FI (1) FI3835298T3 (https=)
MX (1) MX2022007155A (https=)
WO (1) WO2021118629A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102674902B1 (ko) 2016-12-01 2024-06-14 아비나스 오퍼레이션스, 인코포레이티드 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체
EP3932922A4 (en) 2019-02-25 2022-05-11 ShanghaiTech University SULPHUR-CONTAINING COMPOUND BASED ON A GLUTARIMIDE FRAMEWORK AND ITS USE
WO2021023233A1 (zh) 2019-08-05 2021-02-11 上海科技大学 Egfr蛋白降解剂及其抗肿瘤应用
IL320609A (en) 2019-08-26 2025-07-01 Arvinas Operations Inc Methods for treating breast cancer with a history of tetrahydronaphthalene as estrogen receptor-disrupting agents
FI3835298T3 (fi) * 2019-12-12 2024-07-29 Accutar Biotechnology Inc Uusia kromaanijohdannaisia, joilla on estrogeenireseptoria hajottava vaikutus, ja niiden käyttötapoja
WO2021133886A1 (en) * 2019-12-23 2021-07-01 Accutar Biotechnology Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer
CA3169011A1 (en) * 2020-02-25 2021-09-02 Xiaobao Yang Glutarimide skeleton-based compounds and uses thereof
AR123492A1 (es) 2020-09-14 2022-12-07 Arvinas Operations Inc Formas cristalinas y amorfas de un compuesto para la degradación dirigida del receptor de estrógeno
EP4289841A4 (en) * 2021-02-04 2025-02-19 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Benzo seven-membered ring bifunctional compound and application thereof
WO2022187588A1 (en) * 2021-03-04 2022-09-09 The Regents Of The University Of Michigan Small molecule degraders of estrogen receptor with cereblon ligands
MX2023011166A (es) * 2021-03-29 2023-09-29 Jiangsu Hengrui Pharmaceuticals Co Ltd Compuesto de tetrahidronaftaleno, metodo de preparacion y uso del mismo en medicina.
EP4377296A1 (en) 2021-07-26 2024-06-05 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
AU2022370021B2 (en) * 2021-10-22 2026-04-16 Gluetacs Therapeutics (Shanghai) Co., Ltd. Crbn e3 ligase ligand compound, protein degrading agent developed on the basis of ligand compound, and their applications
CN113816927B (zh) * 2021-11-23 2022-02-25 苏州国匡医药科技有限公司 一种arv-471中间体的制备方法
CN117229286A (zh) 2022-06-14 2023-12-15 海创药业股份有限公司 一种芳香类化合物及其制备方法及在制备雌激素受体降解剂中的用途
WO2024015409A1 (en) * 2022-07-12 2024-01-18 Regents Of The University Of Michigan Chroman derivatives as estrogen receptor degraders
CN116751186B (zh) * 2022-12-23 2024-10-18 南京知和医药科技有限公司 一种雌激素受体调节剂的制备及其用途
WO2024153025A1 (zh) * 2023-01-16 2024-07-25 南京明德新药研发有限公司 取代的苯并七元环化合物及其应用
CN119258223A (zh) * 2023-07-06 2025-01-07 海创药业股份有限公司 一种降解雌激素受体的联合用药物及其用途
WO2025245408A1 (en) 2024-05-22 2025-11-27 Accutar Biotechnology Inc. Chroman-based compounds for treating cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021710A1 (en) * 1996-10-28 2001-09-13 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129627A0 (en) 1996-10-28 2000-02-29 Novo Nordisk As Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129618A0 (en) 1996-10-28 2000-02-29 Novo Nordisk As Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
EP1192945A3 (en) 2000-09-21 2004-03-03 Pfizer Products Inc. Use of an estrogen agonist/antagonist for treating osteoarthritis
EP1465619A1 (en) 2002-01-14 2004-10-13 Nordic Bioscience A/S Suppression of cartilage degradation via the estrogen receptor
WO2003063659A1 (de) 2002-02-01 2003-08-07 Danny Bellens Ablageständer
CA2512000C (en) 2002-12-26 2011-08-09 Eisai Co., Ltd. Selective estrogen receptor modulator
EP2536706B1 (en) 2010-02-11 2017-06-14 Celgene Corporation Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
EP3303326B1 (en) * 2015-05-26 2020-12-16 H. Hoffnabb-La Roche Ag Heterocyclic estrogen receptor modulators and uses thereof
HK1257296A1 (zh) * 2016-07-12 2019-10-18 Accutar Biotechnology Inc. 新的化合物及其用途
KR102674902B1 (ko) * 2016-12-01 2024-06-14 아비나스 오퍼레이션스, 인코포레이티드 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체
FI3835298T3 (fi) * 2019-12-12 2024-07-29 Accutar Biotechnology Inc Uusia kromaanijohdannaisia, joilla on estrogeenireseptoria hajottava vaikutus, ja niiden käyttötapoja

Also Published As

Publication number Publication date
US20210221802A1 (en) 2021-07-22
FI3835298T3 (fi) 2024-07-29
JP2023506155A (ja) 2023-02-15
MX2022007155A (es) 2022-10-07
CA3164202A1 (en) 2021-06-17
US11261178B2 (en) 2022-03-01
WO2021118629A1 (en) 2021-06-17
EP4420728A2 (en) 2024-08-28
EP3835298A1 (en) 2021-06-16
CN115003295B (zh) 2025-05-06
KR20220118460A (ko) 2022-08-25
ES2986594T3 (es) 2024-11-12
KR102942706B1 (ko) 2026-03-20
EP4420728A3 (en) 2024-10-30
CN120665056A (zh) 2025-09-19
US10800770B1 (en) 2020-10-13
JP2025081364A (ja) 2025-05-27
JP7662639B2 (ja) 2025-04-15
EP3835298B1 (en) 2024-06-26
CN115003295A (zh) 2022-09-02

Similar Documents

Publication Publication Date Title
DK3835298T3 (da) Nye chromanderivater med østrogenreceptornedbrydende aktivitet og anvendelser heraf
EP3865568A4 (en) Akkermansia muciniphila strain and use thereof
DK3917616T3 (da) Heterocykliske forbindelser og anvendelse deraf
EP3919483A4 (en) HETEROCYCLIC BENZOPYRIDONE COMPOUND AND USE THEREOF
EP3594203A4 (en) SUBSTITUTED PYRROLIDINE COMPOUND AND ITS USE
EP3594202A4 (en) SUBSTITUTED PYRROLIDINE COMPOUND AND ITS USE
DK3615527T3 (da) Nye azaquinolin-derivater
EP3572400C0 (en) EZH2 INHIBITOR AND ITS USE
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3508580T3 (da) Ny promotor og anvendelse deraf
DK3452463T3 (da) Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf
DK3723752T3 (da) Nye fast former for cannabidiol og anvendelse heraf
IL283533A (en) Pentatein derivatives and their uses
DK3917626T3 (da) Psma-bindende dualmodusradiotracer og terapeutika
DK3555076T3 (da) Nye phenylpropionsyrederivater og anvendelser deraf
DK3509591T3 (da) Nye jak1-selektive inhibitorer og anvendelser deraf
EP3829534C0 (en) BOTANICAL AND BACTERIAL EXTRACTS WITH RETINOL-LIKE ACTIVITY
EP3755143A4 (en) Mobile animal surveillance and distress monitoring
EP4011898A4 (en) 3-hydroxy-5-pregnane-20-one derivative and use thereof
DK4298092T3 (da) Nye pyrimidin-2-yl-sulfonamidderivater
EP3773402C0 (en) LIFTING MECHANISM AND CHAIRS
EP3857983C0 (en) ENERGY SAVING SIGNAL AND PROCEDURE DESIGN
EP3741758A4 (en) BROMODOMAIN INHIBITOR COMPOUND AND ITS USE
EP3856755A4 (en) Terpinoid derivatives and uses thereof
EP3968031A4 (en) Probe assembly and micro vacuum probe station comprising same